With the collaboration of a team of ophthalmologists and neurosurgeons from Tehran and Guilan University of Medical Sciences, the first-ever corneal sensory nerve graft (Corneal Neurotization) surgery in Iran was successfully performed at Farabi Hospital.

With the efforts of the ophthalmology group and the Translational Ophthalmology Research Center of Tehran University of Medical Sciences, corneal stem cell transplantation and limbal reconstruction were performed for the first time in the world at Farabi Hospital.

In 2018, Iran received trachoma elimination certification, and a post-certification care program was developed based on WHO recommendations to be reported over three years.

This research aims to address the lack of access to eye care in remote and underdeveloped areas of Iran by designing and piloting an Eye Health House model. Due to high rates of visual impairments and a shortage of specialized ophthalmic professionals, the study proposes a sustainable solution: training local healthcare workers (such as Behvarz and health monitoring experts) to serve as assistant ophthalmic care providers. These trained personnel will deliver essential eye care services through telemedicine, reducing reliance on temporary mobile medical teams and ensuring long-term access to specialized ophthalmic care, especially for vulnerable populations like children and the elderly.

This study aims to develop a self-management tool to help pregnant women with eye diseases make informed decisions about their mode of delivery. Since no definitive evidence currently guides delivery choices for these conditions, the tool will provide evidence-based support to empower patients in making personalized decisions regarding childbirth interventions.

This research focuses on the use of regenerative sciences in cell therapy for treating various conditions such as neurological injuries, chemical burns, and corneal damage. It explores the potential of skin and hair follicle cells, due to their ectodermal origin and high differentiation ability, for use in cell suspensions to treat acute and chronic corneal injuries. The study aims to extract, cultivate, and preserve cells from hair follicle bulges, with the goal of developing new, life-saving treatments, including limbal stem cell therapy for vision restoration.

A health ministry official stated: A proper lifestyle can reduce the incidence of eye diseases by one-third and delay retinal degeneration by up to 10 years**.

Starting in 2016, the cell therapy project in the field of eye and corneal health will become publicly available in Iran.

The cornea specialist stated: *"It is predicted that by relying on regenerative medicine and stem cells, we will be able to treat hereditary night blindness in the country within the next 10 years."*

According to a report from IRNA, as announced by the Ministry of Health, Treatment, and Medical Education's news and information website (Webda), Dr. Seyed Farzad Mohammadi stated: "Chaharshanbe Suri is a public health crisis, with its impacts primarily focused on certain organs, such as the eyes, skin, and limbs. The Ministry of Health plays a key role in reducing and controlling these injuries." He also emphasized the need for a phenomenological and sociological perspective on the issue of Chaharshanbe Suri and the interventions of relevant institutions in this regard. He added: "If we can attract the attention of sociologists, health specialists, doctors, and other experts to this important phenomenon, we can, through planning over a maximum ten-year period, transform this phenomenon from its current undesirable form into a desirable and normalized event, during which people can celebrate in a healthy way."